Clinical characteristics and natural history of patients with non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations treated with erlotinib or gefitinib.

被引：0
|
作者：
Riely, GJ [1 ]
Miller, VA [1 ]
Pao, W [1 ]
Zakowski, M [1 ]
Ladanyi, M [1 ]
Heelan, RT [1 ]
Kris, MG [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：641S / 641S
页数：1
相关论文
共 50 条
  • [41] Non-small cell lung cancer (NSCLC) patients with rare or complex epidermal growth factor receptor (EGFR) mutations: A single institution series
    Pasello, G.
    Polo, V.
    Frega, S.
    Lorenzi, M.
    Indraccolo, S.
    Fassan, M.
    Bonanno, L.
    Nannini, N.
    Conte, P. F.
    Calabrese, F.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S130 - S130
  • [42] Erlotinib customization based on epidermal growth factor receptor (EGFR) mutations in stage IV non-small-cell lung cancer (NSCLC) patients (p)
    Porta, R.
    Queralt, C.
    Cardenal, F.
    Mayo, C.
    Provencio, M.
    Camps, C.
    Isla, D.
    Gonzalez-Larriba, J.
    Taron, M.
    Rosell, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] Clinical Outcomes in Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring Rare Epidermal Growth Factor Receptor (EGFR) Mutations
    Domingues, Pedro M.
    Montella, Tatiane
    Zukin, Mauro
    Baldotto, Clarissa
    Ferreira, Carlos
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S206 - S207
  • [44] Impact of Smoking History on the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer Harboring Activating Epidermal Growth Factor Receptor Mutations
    Igawa, Satoshi
    Sasaki, Jiichiro
    Otani, Sakiko
    Ishihara, Mikiko
    Takakura, Akira
    Katagiri, Masato
    Masuda, Noriyuki
    [J]. ONCOLOGY, 2015, 89 (05) : 275 - 280
  • [45] Epidermal growth factor receptor mutations are associated with gefitinib sensitivity in non-small cell lung cancer in Japanese
    Uramoto, H
    Sugio, K
    Oyama, T
    Ono, K
    Sugaya, M
    Yoshimatsu, T
    Hanagiri, T
    Morita, M
    Yasumoto, K
    [J]. LUNG CANCER, 2006, 51 (01) : 71 - 77
  • [46] Mutation in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer (NSCLC)
    Tsai, C
    Chiu, C
    Chou, T
    Li, L
    Chang, K
    Chen, Y
    Tsai, S
    Perng, R
    [J]. LUNG CANCER, 2005, 49 : S113 - S113
  • [47] The effect of gefitinib in patients with postoperative recurrent non-small cell lung cancer harboring mutations of the epidermal growth factor receptor
    Ryo Ko
    Hirotsugu Kenmotsu
    Yasushi Hisamatsu
    Hiroaki Akamatsu
    Shota Omori
    Kazuhisa Nakashima
    Takuya Oyakawa
    Kazushige Wakuda
    Takehito Shukuya
    Akira Ono
    Hisao Imai
    Tetsuhiko Taira
    Tateaki Naito
    Haruyasu Murakami
    Keita Mori
    Masahiro Endo
    Yasuhisa Ohde
    Kazuhisa Takahashi
    Toshiaki Takahashi
    [J]. International Journal of Clinical Oncology, 2015, 20 : 668 - 673
  • [48] A prospective phase II study of gefitinib in non-small cell cancer patients with epidermal growth factor receptor gene (EGFR) mutations
    Sugio, K.
    Uramoto, H.
    Oyama, T.
    Onizuka, T.
    Ichiki, Y.
    Yasuda, M.
    Sugaya, M.
    Nozoe, T.
    Takenoyama, M.
    Hanagiri, T.
    Yasumoto, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] The effect of gefitinib in patients with postoperative recurrent non-small cell lung cancer harboring mutations of the epidermal growth factor receptor
    Ko, Ryo
    Kenmotsu, Hirotsugu
    Hisamatsu, Yasushi
    Akamatsu, Hiroaki
    Omori, Shota
    Nakashima, Kazuhisa
    Oyakawa, Takuya
    Wakuda, Kazushige
    Shukuya, Takehito
    Ono, Akira
    Imai, Hisao
    Taira, Tetsuhiko
    Naito, Tateaki
    Murakami, Haruyasu
    Mori, Keita
    Endo, Masahiro
    Ohde, Yasuhisa
    Takahashi, Kazuhisa
    Takahashi, Toshiaki
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (04) : 668 - 673
  • [50] Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutations in Non-small Cell Lung Cancer (NSCLC): A Global Meta-analysis
    Melosky, B.
    Laack, E.
    Kambartel, K.
    Haentschel, M.
    Bennetts, M.
    Nickens, D.
    Brinkmann, J.
    Kayser, A.
    Moran, M.
    Cappuzzo, F.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S449 - S449
12345